Novartis to buy pfizer drug
Novartis will pay up to $225 million to buy an experimental bladder control drug from the US giant Pfizer Inc in what analysts described on Tuesday as a steal for the Swiss healthcare
Related Content
- Pharma majors named in clinical trial death list
- Drugmakers Look to Break Rural Deadlock: Novartis, GlaxoSmithKline, Pfizer & Ranbaxy focus on hinterland
- Wockhardt to sell mktg rights of diabetes drugs
- Pfizer, Novartis, GSK also under USFDA scanner
- Ranbaxy fights Pfizer on generic drugs but wants strong home law on patents
- Patent protest